[go: up one dir, main page]

BR9408195A - Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina - Google Patents

Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina

Info

Publication number
BR9408195A
BR9408195A BR9408195A BR9408195A BR9408195A BR 9408195 A BR9408195 A BR 9408195A BR 9408195 A BR9408195 A BR 9408195A BR 9408195 A BR9408195 A BR 9408195A BR 9408195 A BR9408195 A BR 9408195A
Authority
BR
Brazil
Prior art keywords
hirudin
conjugates
pct
production
lipophilic compounds
Prior art date
Application number
BR9408195A
Other languages
English (en)
Inventor
Jurgen Schweden
Peter Eckes
Wilfried Hornberger
Thomas Subkowski
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9408195A publication Critical patent/BR9408195A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Ink Jet (AREA)
  • Silicon Polymers (AREA)
BR9408195A 1993-12-02 1994-11-25 Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina BR9408195A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4341115 1993-12-02
PCT/EP1994/003901 WO1995015183A1 (de) 1993-12-02 1994-11-25 Hirudin-konjugate aus hirudin und lipophilen verbindungen

Publications (1)

Publication Number Publication Date
BR9408195A true BR9408195A (pt) 1997-08-26

Family

ID=6504029

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9408195A BR9408195A (pt) 1993-12-02 1994-11-25 Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina

Country Status (25)

Country Link
US (1) US5919762A (pt)
EP (1) EP0730473B1 (pt)
JP (1) JPH09505810A (pt)
CN (1) CN1142776A (pt)
AT (1) ATE204763T1 (pt)
AU (1) AU679811B2 (pt)
BR (1) BR9408195A (pt)
CA (1) CA2176967A1 (pt)
CZ (1) CZ157096A3 (pt)
DE (2) DE4437502A1 (pt)
DK (1) DK0730473T3 (pt)
ES (1) ES2163487T3 (pt)
FI (1) FI962299L (pt)
GR (1) GR3036938T3 (pt)
HR (1) HRP940968A2 (pt)
HU (1) HUT74390A (pt)
IL (1) IL111811A0 (pt)
NO (1) NO962261D0 (pt)
NZ (1) NZ276410A (pt)
PL (1) PL314797A1 (pt)
PT (1) PT730473E (pt)
SG (1) SG49156A1 (pt)
SK (1) SK67596A3 (pt)
WO (1) WO1995015183A1 (pt)
ZA (1) ZA949562B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437604A1 (de) * 1994-10-21 1996-04-25 Basf Ag Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
US5726168A (en) * 1995-10-12 1998-03-10 Eli Lilly And Company Lipophilic benzothiophenes
USD438964S1 (en) 1997-11-07 2001-03-13 Graphic Controls Corporation Cabinet and container for housing medical waste
DE19915862A1 (de) * 1999-04-08 2000-10-12 Max Planck Gesellschaft Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie
ATE419897T1 (de) * 2001-10-24 2009-01-15 Power Paper Ltd Vorrichtung für die kontrollierte abgabe eines wirkstoffes in die haut
US7438925B2 (en) * 2002-08-26 2008-10-21 Biovention Holdings Ltd. Drug eluting coatings for medical implants
BR102017005783A2 (pt) * 2017-03-21 2018-10-02 Fund Butantan processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos
KR102366360B1 (ko) * 2021-06-29 2022-02-23 (주)네오팜 신규한 유사 세라마이드 화합물 및 이를 포함하는 피부 외용제 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
US4939174A (en) * 1988-02-26 1990-07-03 Shashoua Victor E Appetite suppression with dopamine-fatty acid conjugates
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
DE69008521T2 (de) * 1989-03-07 1994-10-20 Genentech Inc Kovalente konjugate von lipiden und oligonukleotiden.
DE4014260A1 (de) * 1989-12-01 1991-06-06 Basf Ag Hirudinpolyalkylenglykolkonjugate
DE59010205D1 (de) * 1989-12-01 1996-04-18 Basf Ag Hirudin-Muteine und deren Polyalkylenglykolkonjugate
EP0506748B1 (en) * 1989-12-22 1995-12-13 Commonwealth Scientific And Industrial Research Organisation Amino acids, peptides or derivatives thereof coupled to fats
WO1991014696A1 (en) * 1990-03-29 1991-10-03 Gilead Sciences, Inc. Oligonucleotide-transport agent disulfide conjugates
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
WO1992019233A2 (en) * 1991-04-29 1992-11-12 Control Delivery Systems, Inc. Sustained release composition and methods of use thereof
WO1992019223A1 (fr) * 1991-05-02 1992-11-12 Pierre Baudet Les n-phenyl-cinnamamides, protecteurs contre les effets nocifs de la lumiere ultra-violette
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same

Also Published As

Publication number Publication date
JPH09505810A (ja) 1997-06-10
NZ276410A (en) 1997-03-24
DE59409847D1 (de) 2001-10-04
ES2163487T3 (es) 2002-02-01
HRP940968A2 (en) 1997-08-31
PT730473E (pt) 2002-02-28
NO962261L (no) 1996-05-31
DK0730473T3 (da) 2001-10-08
ATE204763T1 (de) 2001-09-15
EP0730473B1 (de) 2001-08-29
DE4437502A1 (de) 1995-06-08
AU679811B2 (en) 1997-07-10
HU9601471D0 (en) 1996-07-29
AU1067095A (en) 1995-06-19
IL111811A0 (en) 1995-01-24
FI962299A0 (fi) 1996-05-31
NO962261D0 (no) 1996-05-31
SK67596A3 (en) 1996-12-04
GR3036938T3 (en) 2002-01-31
ZA949562B (en) 1996-06-03
HUT74390A (en) 1996-12-30
FI962299A7 (fi) 1996-05-31
CZ157096A3 (en) 1996-09-11
SG49156A1 (en) 1998-05-18
EP0730473A1 (de) 1996-09-11
PL314797A1 (en) 1996-09-30
WO1995015183A1 (de) 1995-06-08
CN1142776A (zh) 1997-02-12
US5919762A (en) 1999-07-06
FI962299L (fi) 1996-05-31
CA2176967A1 (en) 1995-06-08

Similar Documents

Publication Publication Date Title
DE69230144D1 (de) Röntgenkontrastmittel
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
MX9601360A (es) Mezcla estabilizante sinergistica.
NO954320D0 (no) Lyosfærer omfattende gonadotropin
YU56995A (sh) Soli derivata indola
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
BG102259A (en) Compostions with controlled paroxetine release
BR9812837A (pt) Processo para fazer um composto, e, composto
GB9712966D0 (en) Novel chalcones
BR9805031A (pt) Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos.
BR9808923A (pt) Composto, e, processo para fazer o mesmo
BR9408195A (pt) Conjugados de hirudina formados de uma hirudina e um ou vários compostos lipófilos e processo para a produção de conjugados de hirudina
ZA9610771B (en) Process for the preparation of 2-chloro-5-chloromethylthiazole
MX166685B (es) Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas
AU6306190A (en) Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
ES2078787T3 (es) Ariliden-1-azacicloalcanos y arilalquil-1-azacicloalcanos, sus sales, medicamentos que contienen estos compuestos y su empleo, asi como procedimiento para su preparacion.
MX9302429A (es) Nuevas tetralonas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
ES2014445B3 (es) Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos.
ATE157959T1 (de) Indanderivate
GB9410207D0 (en) Process
IT1242475B (it) Agente colinergico, in particolare glicil-p-ammino-piridina-anilide- monoacetato, per il trattamento degli stati di demenza senile.
IL110025A0 (en) Phosphonosuccinic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
BR0010614A (pt) Produção de pseudomicina por pseudomonas syringae
BR9808194A (pt) Uso de um derivado do 7a-metil-17a-etinil-estrano, e, processo para inibir o processo de ateroesclerose

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B15K Others concerning applications: alteration of classification

Ipc: A61K 47/54 (2017.01), A61K 38/00 (2006.0